Date Filed | Type | Description |
08/08/2023 |
4
| KROLL MARK W (Director) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Granted 2,226 shares
@ $0 |
|
05/15/2023 |
4
| KROLL MARK W (Director) has filed a Form 4 on AXON ENTERPRISE, INC.
Txns:
| Granted 993 shares
@ $0 |
|
03/08/2023 |
4
| KROLL MARK W (Director) has filed a Form 4 on AXON ENTERPRISE, INC.
Txns:
| Sold 92 shares
@ $220.85, valued at
$20.3k
Sold 3,457 shares
@ $220.724, valued at
$763k
|
|
08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/14/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/17/2020 |
4
| KROLL MARK W (Director) has filed a Form 4 on AXON ENTERPRISE, INC.
Txns:
| Sold 2,993 shares
@ $120.44, valued at
$360.5k
|
|
07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2020 |
4
| KROLL MARK W (Director) has filed a Form 4 on AXON ENTERPRISE, INC.
Txns:
| Granted 2,107 shares
@ $75.96, valued at
$160k
|
|
04/13/2020 |
4
| KROLL MARK W (Director) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Gifted 870 shares
@ $0 Sold 6,573 shares
@ $102, valued at
$670.4k
Sold 4,329 shares
@ $102, valued at
$441.6k
Exercised 6,573 options to buy
@ $45.45, valued at
$298.7k
|
|
11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/26/2019 |
4
| KROLL MARK W (Director) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Granted 1,460 shares
@ $0 |
|
06/03/2019 |
4
| KROLL MARK W (Director) has filed a Form 4 on AXON ENTERPRISE, INC.
Txns:
| Granted 2,396 shares
@ $66.78, valued at
$160k
|
|
05/24/2019 |
4
| KROLL MARK W (Director) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Gifted 1,449 shares
@ $0 |
|
05/22/2019 |
4
| KROLL MARK W (Director) has filed a Form 4 on AXON ENTERPRISE, INC.
Txns:
| Gifted 952 shares
@ $0 |
|
05/13/2019 |
5
| KROLL MARK W (Director) has filed a Form 5 on HAEMONETICS CORP |
11/09/2018 |
4
| KROLL MARK W (Director) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Gifted 1,000 shares
@ $0 Gifted 200 shares
@ $0 Sold 10,707 shares
@ $114, valued at
$1.2M
Exercised 8,196 options to buy
@ $36.37, valued at
$298.1k
|
|
08/29/2018 |
4
| KROLL MARK W (Director) has filed a Form 4 on AXON ENTERPRISE, INC.
Txns:
| Gifted 1,888 shares
@ $0 |
|
08/20/2018 |
4
| KROLL MARK W (Director) has filed a Form 4 on AXON ENTERPRISE, INC.
Txns:
| Sold 7,097 shares
@ $64.34, valued at
$456.6k
|
|
07/30/2018 |
4
| KROLL MARK W (Director) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Granted 1,696 shares
@ $0 |
|
06/29/2018 |
4
| KROLL MARK W (Director) has filed a Form 4 on AXON ENTERPRISE, INC.
Txns:
| Gifted 2,070 shares
@ $9.43, valued at
$19.5k
Sold 3,100 shares
@ $22.85, valued at
$70.8k
|
|
05/24/2018 |
4
| KROLL MARK W (Director) has filed a Form 4 on AXON ENTERPRISE, INC.
Txns:
| Granted 2,577 shares
@ $62.08, valued at
$160k
|
|
01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/25/2016 |
4
| KROLL MARK W (Director) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Granted 5,746 shares
@ $29.585, valued at
$170k
|
|
|